Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  1,087,580 نتائج ل ""Kinase""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects.

  • Authors : Dickerson H; School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.; Diab A

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/pharmacology ; ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/antagonists & inhibitors

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 17; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma.

  • Authors : Ding Y; Department of Hematology/Hematological Lab, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.; Huang K

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/genetics ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics

  • Source: Scientific reports [Sci Rep] 2024 Sep 11; Vol. 14 (1), pp. 21184. Date of Electronic Publication: 2024 Sep 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia.

  • Authors : Zu Y; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.; Zhao H

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/adverse effects ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Sep 11; Vol. 17 (1), pp. 82. Date of Electronic Publication: 2024 Sep 11.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

×
Academic Journal

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia.

  • Authors : Wu X; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/administration & dosage ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/adverse effects

  • Source: Cancer medicine [Cancer Med] 2024 Sep; Vol. 13 (17), pp. e70161.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Revolutionizing non-melanoma skin cancer treatment: Receptor tyrosine kinase inhibitors take the stage.

  • Authors : Gholizadeh N; Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Rokni GR

Subjects: Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/pathology ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/adverse effects

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Sep; Vol. 23 (9), pp. 2793-2806. Date of Electronic Publication: 2024 May 29.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Bruton's tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia.

  • Authors : Xu LL; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, 430030, China.

Subjects: Agammaglobulinaemia Tyrosine Kinase*/Agammaglobulinaemia Tyrosine Kinase*/Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors ; Agammaglobulinaemia Tyrosine Kinase*/Agammaglobulinaemia Tyrosine Kinase*/Agammaglobulinaemia Tyrosine Kinase*/metabolism ; Brain Ischemia*/Brain Ischemia*/Brain Ischemia*/drug therapy

  • Source: Journal of neuroinflammation [J Neuroinflammation] 2024 Aug 03; Vol. 21 (1), pp. 195. Date of Electronic Publication: 2024 Aug 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094

تفاصيل العنوان

×
  • 1-10 ل  1,087,580 نتائج ل ""Kinase""